Diluted Smallpox Vaccine May Cover Shortage
UPDATED: 10:47 a.m. EST February 7, 2002
Government researchers may have come up with an answer to the smallpox vaccine shortage.
The country has only 15 million doses of the vaccine. Researchers have been testing a diluted version of the immunization and said early results look promising.
They said their findings suggest they can expand the supplies to cover at least 75 million people. Study results are expected to be published in the next few weeks.
Meanwhile, the government is moving ahead to build up the stockpiles.
It has plans to manufacture about 200 million new vaccine doses to supplement the old stockpile and cover the entire U.S. population if need be. The newly manufactured vaccine is forecast to be available by year's end.
The country has only 15 million doses of the vaccine. Researchers have been testing a diluted version of the immunization and said early results look promising.
They said their findings suggest they can expand the supplies to cover at least 75 million people. Study results are expected to be published in the next few weeks.
Meanwhile, the government is moving ahead to build up the stockpiles.
It has plans to manufacture about 200 million new vaccine doses to supplement the old stockpile and cover the entire U.S. population if need be. The newly manufactured vaccine is forecast to be available by year's end.
Previous Stories:
- December 4, 2001: Study: Quarantine Bad Option For Smallpox
- November 28, 2001: U.S. Buys 155 Million Smallpox Vaccine Doses
Copyright 2002 by NewsNet5.com. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.



